$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Sotoraxib combined with panitumumab provides an effective targeted therapy option for patients with KRAS G12C+mCRC
2026-02-01 22:25:32
Check Details
Adagarasib improves prognosis in KRAS G12C mutated lung cancer
2026-02-01 22:25:32
Check Details
Which generation of targeted drug is afatinib? What is its role in lung cancer treatment?
2026-02-01 22:25:32
Check Details
What is the domestic price of 2025 Dali Raisin tablets? Analysis of the latest price information
2026-02-01 22:25:32
Check Details
Lynparib induces improvement in OS rate in platinum-sensitive germline/somatic BRCA+ recurrent ovarian cancer
2026-02-01 22:25:32
Check Details
The CRISTALLO study of venetoclax/venetoclax/Obinutuzumab achieved excellent MRD in CLL
2026-02-01 22:25:32
Check Details
Acemini Price Analysis: Latest Prices and Purchasing Channels in 2025
2026-02-01 22:25:32
Check Details
Study highlights long-term efficacy of ritexitinib in treating alopecia areata
2026-02-01 22:25:32
Check Details
Travere Therapeutics plans to submit sparsentan/sparsentan for the treatment of FSGS
2026-02-01 22:25:32
Check Details
Is Ixazomib/Enleri a chemotherapy drug or a targeted drug? What is its mechanism of action
2026-02-01 22:25:32
Check Details
The LUPER study evaluates rubicatin/rubitin combined with pembrolizumab in the treatment of relapsed small cell lung cancer
2026-02-01 22:25:32
Check Details
Is Pirfenidone/Isrifenidone a hormonal drug? Analysis of pharmacological effects and treatment principles
2026-02-01 22:25:32
Check Details
1
2
...
1378
1379
1380
1381
1382
1383
1384
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
2
Revumenib: Key Considerations Before and During Treatment
3
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
4
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
5
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
6
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
7
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
8
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
9
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
10
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
11
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
12
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure